A detailed history of Cubist Systematic Strategies, LLC transactions in Alvotech stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 11,273 shares of ALVO stock, worth $134,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,273
Previous 13,277 15.09%
Holding current value
$134,261
Previous $161,000 16.77%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.76 - $12.99 $21,563 - $26,031
-2,004 Reduced 15.09%
11,273 $134,000
Q2 2024

Aug 14, 2024

SELL
$11.4 - $14.51 $35,590 - $45,300
-3,122 Reduced 19.04%
13,277 $161,000
Q1 2024

May 15, 2024

BUY
$11.36 - $17.27 $186,292 - $283,210
16,399 New
16,399 $200,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $2.96B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.